Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUSICA: Adalimumab + Methotrexate Dosing in RA
NCT01185288Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2010
- Primary completion
- Jan 2013
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 4 trial of adalimumab in rheumatoid arthritis (RA), sponsored by AbbVie Inc.. Started Sep 2010; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01185288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01185288.